Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Effects of recombinant bactericidal/permeability-increasing protein

Ann Surg. 1995 Apr;221(4):398-405. doi: 10.1097/00000658-199504000-00011.

Abstract

Objectives: This study was conducted to determine the role of gut-derived bacteria/endotoxin in the pathogenesis of the multiple-organ damage and mortality, the possible beneficial effect of recombinant bactericidal/permeability-increasing protein (rBPl21), and whether neutralizing endotoxemia by rBPl21 treatment influences tumor necrosis factor (TNF) formation in rats after hemorrhagic shock and resuscitation.

Summary background data: Hypovolemic shock might be associated with bacterial or endotoxin translocation as well as systemic sepsis. Similar to bactericidal/permeability-increasing (BPl) protein, rBPl21 has been found to bind endotoxin and inhibit TNF production.

Methods: A rat model of prolonged hemorrhagic shock (30 to 35 mm Hg for 180 min) followed by adequate resuscitation was employed. Recombinant bactericidal/permeability-increasing protein was administered at 5 mg/kg intravenously. The control group was treated similarly to the BPl group, but received thaumatin as a protein-control preparation in the same dose as rBPl21.

Results: Immediately after resuscitation (230 min), plasma endotoxin levels in the control group (61.0 +/- 16.3 pg/mL) were almost neutralized by rBPl21 treatment (13.8 +/- 4.8 pg/mL, p < 0.05). Plasma TNF levels were not significantly influenced by rBPl21 treatment. The 48-hour survival rate was 68.8% in the treatment group versus 37.5% in the control group (p = 0.08). Microscopic histopathologic examination revealed relatively minor damage to various organs in the treatment group.

Conclusions: These data suggest that hemorrhagic shock may lead to bacterial/endotoxin translocation with concomitant TNF formation, endogenous endotoxemia may play an important role in the pathogenesis of multiple-organ failure after shock and trauma, TNF formation at an early stage might be related mainly to mechanisms other than Kupffer's cells activation via lipopolysaccharide, and rBPl21 might be a useful therapeutic agent against endogenous bacteria/endotoxin related disorders in severe hemorrhagic shock.

MeSH terms

  • Animals
  • Antimicrobial Cationic Peptides
  • Blood Proteins / therapeutic use*
  • Cell Movement
  • Endotoxins / pharmacokinetics*
  • Escherichia coli / physiology*
  • Male
  • Membrane Proteins*
  • Peptide Fragments / pharmacology*
  • Permeability
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins / therapeutic use
  • Shock, Hemorrhagic / metabolism
  • Shock, Hemorrhagic / microbiology*
  • Shock, Hemorrhagic / therapy
  • Toxemia / metabolism
  • Toxemia / microbiology
  • Toxemia / therapy*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antimicrobial Cationic Peptides
  • Blood Proteins
  • Endotoxins
  • Membrane Proteins
  • Peptide Fragments
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • bactericidal permeability increasing protein